Form 4: Medpace Exec. Exercises Stock Options

Medpace Holdings, Inc. Executive Vice President of Operations, Susan E. Burwig, exercised 10,000 employee stock options at $107.93 per share.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), exercised 10,000 employee stock options on December 5, 2025.
• The exercise price for these options was $107.93 per share.
• Following this transaction, Ms. Burwig directly owns 47,500 shares of Medpace Holdings, Inc. common stock.
• The options exercised were part of an employee stock option grant that vested in full on February 28, 2020, and are set to expire on February 28, 2026.
• After exercising 10,000 options, Ms. Burwig beneficially owns 10,984 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as an executive exercising options often indicates confidence in the company's stock value and future prospects, representing a personal financial gain for the insider. However, it's a routine disclosure and doesn't directly impact company operations or financial results.

Positives

• An executive exercising stock options can signal confidence in the company's future performance and the value of its stock.
• The transaction represents a personal gain for the executive, as the options were exercised at a specific price, implying the market price was at or above this level.

Future Outlook

This Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of an insider transaction and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's compensation activity within the pharmaceutical and clinical research industry.

Stakeholder Impact

• Shareholders may view the executive's exercise of options as a positive signal, suggesting insider confidence in the company's valuation and future growth.
• Employees may see this as a standard executive compensation event, potentially reinforcing the value of their own equity-based incentives.

Key Dates

Keywords

Medpace Holdings, MEDP, Insider Transaction, Stock Options, Executive Compensation, Form 4, Securities Exchange Act